Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Bacon is a prominent Argentine pharmaceutical company dedicated to the field of nuclear medicine and radiopharmaceuticals. Established in 1991, the company specializes in the production of radioisotopes and labeled compounds for both diagnostic imaging (PET and SPECT) and radionuclide therapy. Their facilities include high-energy cyclotrons and GMP-compliant laboratories, enabling the supply of critical products like Fluorodeoxyglucose (FDG), Iodine-131, and Technetium-99m generators. Laboratorios Bacon plays a vital role in the healthcare infrastructure of South America, providing advanced molecular imaging tools for oncology, cardiology, and neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Bacon.